Products
LOGIQ™ E10 Ultrasound Series
Next-generation, leadership ultrasound that adapts to your needs, today and into the future.
SIGNA™ PET/MR with QuantWorks – 60cm
Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with innovative Q.Clear reconstruction delivers 2x improvement in image quality. In addition, SIGNA PET/MR with QuantWorks includes a comprehensive suite of applications and flexible research tools to pursue ideas that could influence the future of medicineREADY View
Quantified MR image analysis to enable accurate, confident diagnoses.
8. Effect of screening and adjuvant therapy on mortality from breast cancer. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M. et al. N Engl J Med. 2005;353:1784–92.doi:10.1056/NEJMoa050518.
9. Breast Cancer Res. 2017 Sep 11;19(1):106. doi: 10.1186/s13058-017-0899-1.Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging. Iotti V1, Ravaioli S2, Vacondio R2, Coriani C2, Caffarri S3, Sghedoni R4, Nitrosi A4, Ragazzi M5, Gasparini E6, Masini C7, Bisagni G7, Falco G8, Ferrari G8, Braglia L9, Del Prato A2, Malavolti I3, Ginocchi V3, Pattacini P2. Breast Cancer Res. 2017 Sep 11;19(1):106. doi: 10.1186/s13058-017-0899-1.
10. Mammography,Imaging Neoadjuvant Therapy.Response in Breast Cancer. Amy M. Fowler, MD, PhDDavid A. Mankoff, MD, PhD,Bonnie N. Joe, MD, PhD. radiology.rsna.org n Radiology: Volume 285: Number 2—November 2017
11. 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer. Stefanie Avril, Raymond F. Muzic Jr., Donna Plecha, Bryan J. Traughber, Shaveta Vinayak, and Norbert Avril. Nucl Med. 2016 February ; 57(Suppl 1): 34S–39S. doi:10.2967/jnumed.115.157875.
9. Breast Cancer Res. 2017 Sep 11;19(1):106. doi: 10.1186/s13058-017-0899-1.Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging. Iotti V1, Ravaioli S2, Vacondio R2, Coriani C2, Caffarri S3, Sghedoni R4, Nitrosi A4, Ragazzi M5, Gasparini E6, Masini C7, Bisagni G7, Falco G8, Ferrari G8, Braglia L9, Del Prato A2, Malavolti I3, Ginocchi V3, Pattacini P2. Breast Cancer Res. 2017 Sep 11;19(1):106. doi: 10.1186/s13058-017-0899-1.
10. Mammography,Imaging Neoadjuvant Therapy.Response in Breast Cancer. Amy M. Fowler, MD, PhDDavid A. Mankoff, MD, PhD,Bonnie N. Joe, MD, PhD. radiology.rsna.org n Radiology: Volume 285: Number 2—November 2017
11. 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer. Stefanie Avril, Raymond F. Muzic Jr., Donna Plecha, Bryan J. Traughber, Shaveta Vinayak, and Norbert Avril. Nucl Med. 2016 February ; 57(Suppl 1): 34S–39S. doi:10.2967/jnumed.115.157875.
WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606